Cargando…
Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Leishmania
Leishmaniasis is a health-threatening vector-borne disease in almost 90 different countries. While a prophylactic human vaccine is not yet available, the fact that recovery from leishmaniasis establishes lifelong immunity against secondary infection suggests that a vaccine is attainable. In the past...
Autores principales: | Seyed, Negar, Peters, Nathan C., Rafati, Sima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996938/ https://www.ncbi.nlm.nih.gov/pubmed/29922288 http://dx.doi.org/10.3389/fimmu.2018.01227 |
Ejemplares similares
-
Leishmania tarentolae as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice Model
por: Lajevardi, Mahya Sadat, et al.
Publicado: (2022) -
Post-Genomics and Vaccine Improvement for Leishmania
por: Seyed, Negar, et al.
Publicado: (2016) -
Evaluation of Leishmanization Using Iranian Lizard Leishmania Mixed With CpG-ODN as a Candidate Vaccine Against Experimental Murine Leishmaniasis
por: Keshavarzian, Nafiseh, et al.
Publicado: (2020) -
Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2014) -
CD8(+) T Cells in Leishmania Infections: Friends or Foes?
por: Stäger, Simona, et al.
Publicado: (2012)